You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Metastases

Pegylated liposomal irinotecan for treating pancreatic cancer after gemcitabine

  • Technology appraisal guidance
  • Reference number: TA440
  • Published:  26 April 2017
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

On this page

  1. Final appraisal determination
  2. Draft guidance: 1
  3. Invitation to participate
  4. Draft scope documents

History

A list of downloadable documents created during development.

Final appraisal determination

  • Final appraisal determination

  • Final appraisal determination document (PDF 461 KB)

    Published:
    28 March 2017
  • Committee papers (PDF 1.57 MB)

    Published:
    28 March 2017
  • Public committee slides (PDF 198 KB)

    Published:
    28 March 2017

Draft guidance: 1

  • Draft guidance: 1

  • Appraisal consultation document (PDF 343 KB)

    Published:
    15 November 2016
  • Committee papers (PDF 8.51 MB)

    Published:
    12 April 2017
  • Public committee slides (PDF 103 KB)

    Published:
    12 April 2017
  • Public committee slides (PDF 223 KB)

    Published:
    12 April 2017

Invitation to participate

  • Equality impact assessment (Scoping) (PDF 62 KB)

    Published:
    25 February 2016
  • Final scope (PDF 103 KB)

    Published:
    25 February 2016
  • Final matrix (PDF 100 KB)

    Published:
    25 February 2016
  • NICE's response to comments on the draft scope and provisional matrix (PDF 143 KB)

    Published:
    25 February 2016

Draft scope documents

  • Draft scope (pre-referral) (PDF 137 KB)

    Published:
    04 February 2016
  • Provisional matrix (pre-referral) (PDF 101 KB)

    Published:
    04 February 2016